Purchase Order 36C26125P1544
Award Date
9/9/25
Potential Completion Date
11/9/25
Potential Value
$77K
Federal Agency
Veterans Integrated Service Network 21
Awardee
Biologics, Inc.
Ultimate Awardee
Mckesson Corporation
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cary, NC 27513, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $20,432.27 firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the emergency procurement of the cancer medication Lenalidomide. The contract has an ultimate completion date of September 30, 2025 and was awarded on August 21, 2025. Biologics, Inc. is a for-profit pharmaceutical company that specializes in delivering critical medical treatments, particularly...
This is a $21,535.58 firm fixed-price purchase order awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a for-profit pharmaceutical provider. The order is for cancer drug biologics to be delivered by November 30, 2024. Biologics, Inc. is a subsidiary of the larger McKesson Corporation, which is a major healthcare services and IT company that has provided over $5.8 million in pharmaceutical products to the Department of Veterans Affairs and Indian Health...
This is a $22,061.05 firm fixed-price purchase order awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the supply of cancer drugs and biologics in fiscal year 2025. The contract has no set-aside designation, indicating open competition. Biologics, Inc. is a pharmaceutical company focused on delivering critical medical treatments, particularly cancer medications, to various federal healthcare and correctional...
This is a firm fixed-price purchase order for $91,279.43 awarded by the Veterans Integrated Service Network 22, a component of the Department of Veterans Affairs (VA), to Biologics, Inc. to provide the cancer medication Lynparza on an emergency basis. The contract period was from November 6, 2015 to September 30, 2016. This contract was not set aside for any specific business category. Biologics, Inc. is a for-profit pharmaceutical company that has provided specialty medications to various...
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order to Mckesson Plasma And Biologics LLC, a subsidiary of Mckesson Corporation, for the delivery of belzutifan 40mg capsules. The contract, valued at $22,051.39, has an ultimate completion date of April 30, 2025. The award was made through the Veterans Integrated Service Network 2 (VISN 2), a regional network within the VA's healthcare system. The contract does not have a set-aside designation. Mckesson Plasma And...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 9 to Mckesson Corporation, a prime contractor that provides pharmaceuticals and medical supplies to federal government customers. The $89,846.40 contract is for the delivery of unspecified "EMERGENCY BICNU" products, with an ultimate completion date of April 8, 2017. Mckesson is a healthcare services and information technology company that has received over...
This federal contract award, with an ID of 36C26325P0747, was issued by the Veterans Integrated Service Network 23 (VISN 23) for the supply of chemotherapy medicines. The contract has a ceiling value of $27,031.66 and is a firm fixed-price purchase order with an ultimate completion date of April 30, 2025. The prime contractor is Mckesson Corporation, a prominent healthcare services and information technology company that provides pharmaceutical, medical supply, and healthcare solutions to...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency, to McKesson Plasma and Biologics LLC, a subsidiary of the healthcare services company McKesson Corporation. The $3,730.60 contract is for the delivery of pharmaceutical products, including specialty drugs and biologics, to support the NIH Clinical Center's healthcare services and clinical research efforts. No set-aside designation was used for this award. McKesson...
This is a federal contract award to McKessonCorporation, a prominent healthcare services and IT company, by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA). The contract, valued at $14,439.25, is for the emergency procurement of Leukeran (chlorambucil) 2mg tablets. This is a firm fixed-price purchase order with a completion date of July 22, 2025. The contract does not have a set-aside designation, indicating McKessonCompetesmicro for this...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs to McKesson Corporation, a prime contractor, for the delivery of MELPHALAN INJ 50 MG VIALS. The contract has a ceiling value of $89,828.16 and a period of performance ending on December 14, 2016. No set-aside designation was used. Based on the information provided, McKesson Corporation, also known as McKesson Drug Company, is a healthcare services and information technology company that provides...